CME Group said full-year 2024 revenue was $6.1 billion, up 10%, operating income was $3.9 billion, net income was $3.5 billion and diluted earnings per share were $9.67.

1. 01

   CME Group said full-year 2024 revenue was $6.1 billion, up 10%, operating income was $3.9 billion, net income was $3.5 billion and diluted earnings per share were $9.67.

2. 02

   The company reported Q4 2024 revenue of $1.5 billion, operating income of $947 million, net income of $875 million and diluted earnings per share of $2.40. On an adjusted basis, net income was $919 million and diluted earnings per share were $2.52.

3. 03

   CME Group said Q4 2024 average daily volume was 25.5 million contracts, in line with Q4 2023. Clearing and transaction fees revenue for the quarter totaled $1.2 billion and market data revenue was $182 million.

4. 04

   The company said as of December 31, 2024 it had approximately $3.1 billion in cash and $3.4 billion of debt. It declared dividends during 2024 of $3.8 billion and on February 6, 2025 declared a Q1 dividend of $1.25 per share.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.